Tekla Healthcare Valuation
| HQH Stock | USD 16.13 0.01 0.06% |
At this time, the company appears to be fairly valued. Tekla Healthcare Inv has a current Real Value of $16.3 per share. The regular price of the company is $16.13. Our model measures the value of Tekla Healthcare Inv from inspecting the company fundamentals such as Return On Equity of 0.061, shares outstanding of 50.62 M, and Operating Margin of (0.22) % as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend purchasing undervalued stocks and trading away overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Tekla Healthcare's valuation include:
Price Book 0.8467 | Enterprise Value 797.5 M | Price Sales 76.6239 | Trailing PE 14.7982 |
Fairly Valued
Today
Please note that Tekla Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Tekla Healthcare Inv is based on 3 months time horizon. Increasing Tekla Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Tekla Healthcare Investors is useful when determining the fair value of the Tekla stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Tekla Healthcare. Since Tekla Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tekla Stock. However, Tekla Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.13 | Real 16.3 | Hype 16.13 | Naive 16.01 |
The real value of Tekla Stock, also known as its intrinsic value, is the underlying worth of Tekla Healthcare Inv Company, which is reflected in its stock price. It is based on Tekla Healthcare's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Tekla Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tekla Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tekla Healthcare Investors helps investors to forecast how Tekla stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tekla Healthcare more accurately as focusing exclusively on Tekla Healthcare's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tekla Healthcare's intrinsic value based on its ongoing forecasts of Tekla Healthcare's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tekla Healthcare's closest peers. When choosing an evaluation method for Tekla Healthcare Inv, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Tekla Healthcare Investments |
|
Tekla Valuation Trend
Knowing Tekla Healthcare's actual value is paramount for traders to make sound investment determinations. Tekla Healthcare's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Tekla Healthcare's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Tekla Healthcare's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Tekla Market Cap
Tekla Healthcare Investors is one of the top stocks in market capitalization category among related companies. Market capitalization of Financials industry is currently estimated at about 826.5 Million. Tekla Healthcare totals roughly 816.58 Million in market capitalization claiming about 99% of equities under Financials industry.Tekla Healthcare Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Tekla Healthcare's current stock value. Our valuation model uses many indicators to compare Tekla Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tekla Healthcare competition to find correlations between indicators driving Tekla Healthcare's intrinsic value. More Info.Tekla Healthcare Investors is one of the top stocks in price to earning category among related companies. It is one of the top stocks in price to book category among related companies fabricating about 0.25 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Tekla Healthcare Investors is roughly 3.99 . The Tekla Healthcare's current Price To Book Ratio is estimated to increase to 1.00. Comparative valuation analysis is a catch-all model that can be used if you cannot value Tekla Healthcare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tekla Healthcare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tekla Healthcare's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Tekla Healthcare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Tekla Healthcare and how it compares across the competition.
About Tekla Healthcare Valuation
The stock valuation mechanism determines the current worth of Tekla Healthcare Investors on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Tekla Healthcare Investors. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Tekla Healthcare Inv based exclusively on its fundamental and basic technical indicators. By analyzing Tekla Healthcare's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Tekla Healthcare's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tekla Healthcare. We calculate exposure to Tekla Healthcare's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Tekla Healthcare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 66.8 M | 70.2 M | |
| Pretax Profit Margin | 1.11 | 1.09 | |
| Operating Profit Margin | 1.11 | 1.09 | |
| Net Profit Margin | 1.11 | 1.09 | |
| Gross Profit Margin | 0.93 | 1.06 |
8 Steps to conduct Tekla Healthcare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Tekla Healthcare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Tekla Healthcare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Tekla Healthcare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Tekla Healthcare's revenue streams: Identify Tekla Healthcare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Tekla Healthcare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Tekla Healthcare's growth potential: Evaluate Tekla Healthcare's management, business model, and growth potential.
- Determine Tekla Healthcare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Tekla Healthcare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Tekla Healthcare represents a small ownership stake in the entity. As a stockholder of Tekla, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Tekla Healthcare Dividends Analysis For Valuation
The Tekla Healthcare's current Dividends Paid is estimated to increase to about 37.7 M. As of now, Tekla Healthcare's Earnings Yield is decreasing as compared to previous years. The Tekla Healthcare's current Price Earnings Ratio is estimated to increase to 16.48, while Retained Earnings are projected to decrease to under 5.1 M.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 35.9 M | 37.7 M | |
| Dividend Yield | 0.00 | 0.00 | |
| Dividend Payout Ratio | 0.00 | 0.00 | |
| Dividend Paid And Capex Coverage Ratio | 0.00 | 0.00 |
There are various types of dividends Tekla Healthcare can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Tekla shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Tekla Healthcare Investors directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Tekla pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Tekla Healthcare by the value of the dividends paid out.
Tekla Healthcare Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Tekla Healthcare does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 49.4 M | |
| Quarterly Earnings Growth Y O Y | -0.667 |
Tekla Healthcare Current Valuation Indicators
Valuation refers to the process of determining the present value of Tekla Healthcare Investors and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Tekla we look at many different elements of the entity such as Tekla's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Tekla Healthcare's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Tekla Healthcare's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tekla Healthcare, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tekla Healthcare's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tekla Healthcare's worth.When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Tekla Stock analysis
When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Tekla Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.67) | Dividend Share 1.61 | Earnings Share 1.09 | Revenue Per Share 0.208 | Quarterly Revenue Growth 0.081 |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.